Literature DB >> 14556662

Characterization of cell death induced by ethacrynic acid in a human colon cancer cell line DLD-1 and suppression by N-acetyl-L-cysteine.

Shu Aizawa1, Keizou Ookawa, Toshihiro Kudo, Junpei Asano, Makoto Hayakari, Shigeki Tsuchida.   

Abstract

Since ethacrynic acid (EA), an SH modifier as well as glutathione S-transferase (GST) inhibitor, has been suggested to induce apoptosis in some cell lines, its effects on a human colon cancer cell line DLD-1 were examined. EA enhanced cell proliferation at 20-40 microM, while it caused cell death at 60-100 microM. Caspase inhibitors did not block cell death and DNA ladder formation was not detected. Poly(ADP-ribose) polymerase, however, was cleaved into an 82-kDa fragment, different from an 85-kDa fragment that is specific for apoptosisis. The 82-kDa fragment was not recognized by antibody against PARP fragment cleaved by caspase 3. N-Acetyl-L-cysteine (NAC) completely inhibited EA-induced cell death, but 3(2)-t-butyl-4-hydroxyanisole or pyrrolidinedithiocarbamate ammonium salt did not. Glutathione (GSH) levels were dose-dependently increased in cells treated with EA and this increase was hardly affected by NAC addition. Mitogen-activated protein kinase (MAPK) kinase (MEK) 1, extracellular signal-regulated kinase (ERK) 1 and GST P1-1 were increased in cells treated with 25-75 microM EA, while c-Jun N-terminal kinase (JNK) 1 and p38 MAPK were markedly decreased by 100 microM EA. NAC repressed EA-induced alterations in these MAPKs and GST P1-1. p38 MAPK inhibitors, SB203580 and FR167653, dose-dependently enhanced EA-induced cell death. An MEK inhibitor, U0126, did not affect EA-induced cell death. These studies revealed that EA induced cell death concomitantly with a novel PARP fragmentation, but without DNA fragmentation. p38 MAPK was suggested to play an inhibitory role in EA-induced cell death.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14556662     DOI: 10.1111/j.1349-7006.2003.tb01371.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  12 in total

1.  Inhibitory effects of ethacrynic acid analogues lacking the α,β-unsaturated carbonyl unit and para-acylated phenols on human cancer cells.

Authors:  Zack E Bryant; Romy F J Janser; Medina Jabarkhail; Melissa S Candelaria-Lyons; Brittni B Romero; Severine Van slambrouck; Wim F A Steelant; Ingo Janser
Journal:  Bioorg Med Chem Lett       Date:  2010-12-19       Impact factor: 2.823

2.  Ethacrynic acid analogues lacking the alpha,beta-unsaturated carbonyl unit--potential anti-metastatic drugs.

Authors:  Romy F J Janser; Ranjith K Meka; Zack E Bryant; Enoch A Adogla; Elizabeth K Vogel; Jaimie L Wharton; Cynthia M Tilley; Catherine N Kaminski; Seth L Ferrey; Severine Van Slambrouck; Wim F A Steelant; Ingo Janser
Journal:  Bioorg Med Chem Lett       Date:  2010-02-02       Impact factor: 2.823

3.  The metabolic bioactivation of caffeic acid phenethyl ester (CAPE) mediated by tyrosinase selectively inhibits glutathione S-transferase.

Authors:  Shashi K Kudugunti; Helen Thorsheim; Mohammad S Yousef; Lan Guan; Majid Y Moridani
Journal:  Chem Biol Interact       Date:  2011-03-31       Impact factor: 5.192

4.  Ethacrynic acid and cinnamic acid combination exhibits selective anticancer effects on K562 chronic myeloid leukemia cells.

Authors:  Münevver Yenigül; İsmail Akçok; Emel Başak Gencer Akçok
Journal:  Mol Biol Rep       Date:  2022-05-18       Impact factor: 2.742

5.  Amide derivatives of ethacrynic acid: synthesis and evaluation as antagonists of Wnt/beta-catenin signaling and CLL cell survival.

Authors:  Guangyi Jin; Desheng Lu; Shiyin Yao; Christina C N Wu; Jerry X Liu; Dennis A Carson; Howard B Cottam
Journal:  Bioorg Med Chem Lett       Date:  2008-12-24       Impact factor: 2.823

Review 6.  Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment.

Authors:  Larion Santiago; Garrett Daniels; Dongwen Wang; Fang-Ming Deng; Peng Lee
Journal:  Am J Cancer Res       Date:  2017-06-01       Impact factor: 6.166

7.  Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: the role of glutathione S-transferase p1-1.

Authors:  Rui Wang; Changda Liu; Lijuan Xia; Guisen Zhao; Janice Gabrilove; Samuel Waxman; Yongkui Jing
Journal:  Clin Cancer Res       Date:  2012-10-18       Impact factor: 12.531

8.  Multidrug resistance-associated protein 1 (MRP1) mediated vincristine resistance: effects of N-acetylcysteine and Buthionine sulfoximine.

Authors:  Ilhan Akan; Selma Akan; Hakan Akca; Burhan Savas; Tomris Ozben
Journal:  Cancer Cell Int       Date:  2005-07-24       Impact factor: 5.722

9.  Ethacrynic acid exhibits selective toxicity to chronic lymphocytic leukemia cells by inhibition of the Wnt/beta-catenin pathway.

Authors:  Desheng Lu; Jerry X Liu; Tomoyuki Endo; Haowen Zhou; Shiyin Yao; Karl Willert; Ingo G H Schmidt-Wolf; Thomas J Kipps; Dennis A Carson
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

10.  Wnt/ß-catenin: a new therapeutic approach to acute myeloid leukemia.

Authors:  Y Kim; S Thanendrarajan; I G H Schmidt-Wolf
Journal:  Leuk Res Treatment       Date:  2011-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.